53 related articles for article (PubMed ID: 2660131)
1. Peptide YY: intrapancreatic localization and effects on insulin and glucagon secretion in the mouse.
Böttcher G; Ahrén B; Lundquist I; Sundler F
Pancreas; 1989; 4(3):282-8. PubMed ID: 2660131
[TBL] [Abstract][Full Text] [Related]
2. Amylin-like immunoreactivity in the extra-islet peptide YY-producing and glucagon-immunoreactive cells in Japanese quail pancreas.
Yanagida B; Yamamoto T; Suzuki H
Anat Histol Embryol; 2024 Jul; 53(4):e13074. PubMed ID: 38864153
[TBL] [Abstract][Full Text] [Related]
3. Optogenetic stimulation of cholinergic fibers for the modulation of insulin and glycemia.
Fontaine AK; Ramirez DG; Littich SF; Piscopio RA; Kravets V; Schleicher WE; Mizoguchi N; Caldwell JH; Weir RFF; Benninger RKP
Sci Rep; 2021 Feb; 11(1):3670. PubMed ID: 33574598
[TBL] [Abstract][Full Text] [Related]
4. Synchronization of pancreatic islet oscillations by intrapancreatic ganglia: a modeling study.
Fendler B; Zhang M; Satin L; Bertram R
Biophys J; 2009 Aug; 97(3):722-9. PubMed ID: 19651030
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of glucagon and pancreatic polypeptide on rat endocrine pancreas: coexistence in rat islet cells.
Huang YH; Sun MJ; Jiang M; Fu BY
Eur J Histochem; 2009 Jun; 53(2):e10. PubMed ID: 30256861
[TBL] [Abstract][Full Text] [Related]
6. Peptide YY (PYY) Gene Polymorphisms in the 3'-Untranslated Region and Proximal Promoter Regions Regulate Cellular Gene Expression and PYY Secretion and Metabolic Syndrome Traits in Vivo.
Shih PB; Wang L; Chiron S; Wen G; Nievergelt C; Mahata M; Khandrika S; Rao F; Fung MM; Mahata SK; Hamilton BA; O'Connor DT
Endocr Rev; 2009 Dec; 30(7):934. PubMed ID: 28199513
[No Abstract] [Full Text] [Related]
7. Correction to: Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation.
Merino B; Casanueva-Álvarez E; Quesada I; González-Casimiro CM; Fernández-Díaz CM; Postigo-Casado T; Leissring MA; Kaestner KH; Perdomo G; Cózar-Castellano I
Diabetologia; 2024 Jan; 67(1):218-219. PubMed ID: 37966551
[No Abstract] [Full Text] [Related]
8. GLP-1 and PYY for the treatment of obesity: a pilot study on the use of agonists and antagonists in diet-induced rats.
Oertel M; Ziegler CG; Kohlhaas M; Nickel A; Kloock S; Maack C; Sequeira V; Fassnacht M; Dischinger U
Endocr Connect; 2024 Mar; 13(3):. PubMed ID: 38300808
[TBL] [Abstract][Full Text] [Related]
9. Insights into the mechanism of growth and fat deposition by feeding different levels of lipid provided by transcriptome analysis of swamp eel (
Zhang Y; Guo F; Yang X; Liu Y; Bao Y; Wang Z; Hu Z; Zhou Q
Front Immunol; 2023; 14():1118198. PubMed ID: 37404827
[TBL] [Abstract][Full Text] [Related]
10. RISING STARS: Endocrine regulation of metabolic homeostasis via the intestine and gut microbiome.
Meyer RK; Duca FA
J Endocrinol; 2023 Aug; 258(2):. PubMed ID: 37171833
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats.
Sridhar A; Khan D; Abdelaal M; Elliott JA; Naughton V; Flatt PR; Le Roux CW; Docherty NG; Moffett CR
PLoS One; 2022; 17(9):e0274788. PubMed ID: 36137097
[TBL] [Abstract][Full Text] [Related]
12. Enteroendocrine Hormone Secretion and Metabolic Control: Importance of the Region of the Gut Stimulation.
Xie C; Jones KL; Rayner CK; Wu T
Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32825608
[TBL] [Abstract][Full Text] [Related]
13. Targeting Islets: Metabolic Surgery Is More than a Bariatric Surgery.
Chen X; Zhang J; Zhou Z
Obes Surg; 2019 Sep; 29(9):3001-3009. PubMed ID: 31187459
[TBL] [Abstract][Full Text] [Related]
14. Defining G protein-coupled receptor peptide ligand expressomes and signalomes in human and mouse islets.
Atanes P; Ruz-Maldonado I; Hawkes R; Liu B; Zhao M; Huang GC; Al-Amily IM; Salehi A; Amisten S; Persaud SJ
Cell Mol Life Sci; 2018 Aug; 75(16):3039-3050. PubMed ID: 29455414
[TBL] [Abstract][Full Text] [Related]
15. Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.
Guida C; McCulloch LJ; Godazgar M; Stephen SD; Baker C; Basco D; Dong J; Chen D; Clark A; Ramracheya RD
Diabetes Obes Metab; 2018 Mar; 20(3):571-581. PubMed ID: 28892258
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro degradation of peptide YY3-36 to inactive peptide YY3-34 in humans.
Toräng S; Bojsen-Møller KN; Svane MS; Hartmann B; Rosenkilde MM; Madsbad S; Holst JJ
Am J Physiol Regul Integr Comp Physiol; 2016 May; 310(9):R866-74. PubMed ID: 26818056
[TBL] [Abstract][Full Text] [Related]
17. NPY signalling in early osteoblasts controls glucose homeostasis.
Lee NJ; Nguyen AD; Enriquez RF; Luzuriaga J; Bensellam M; Laybutt R; Baldock PA; Herzog H
Mol Metab; 2015 Mar; 4(3):164-74. PubMed ID: 25737952
[TBL] [Abstract][Full Text] [Related]
18. Combination of peptide YY3-36 with GLP-1(7-36) amide causes an increase in first-phase insulin secretion after IV glucose.
Tan TM; Salem V; Troke RC; Alsafi A; Field BC; De Silva A; Misra S; Baynes KC; Donaldson M; Minnion J; Ghatei MA; Godsland IF; Bloom SR
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2317-24. PubMed ID: 25144632
[TBL] [Abstract][Full Text] [Related]
19. Peptide YY: more than just an appetite regulator.
Persaud SJ; Bewick GA
Diabetologia; 2014 Sep; 57(9):1762-9. PubMed ID: 24917132
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
